Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Astrocyte-to-Motoneuron Reprogramming via 4F Transcription F
2026-06-15
This study demonstrates that a specific cocktail of four transcription factors (Ascl1, Myt1l, Pou3f2, Isl1) can reprogram rat and human spinal astrocytes into motoneuron-like cells. The findings provide new insights for regenerative strategies in spinal cord injury by harnessing endogenous cell populations.
-
Calpain Inhibitor II, ALLM: Optimizing Protease Inhibition i
2026-06-15
Calpain Inhibitor II, ALLM empowers researchers to dissect cysteine protease-driven mechanisms in leukemia, lymphoma, and advanced breast cancer models. This article translates cutting-edge mechanistic insights and practical troubleshooting tips into robust, reproducible workflows.
-
CBD Attenuates Orofacial Inflammatory Pain via Cannabinoid a
2026-06-14
This study demonstrates that cannabidiol (CBD) effectively reduces both the sensory and affective aspects of orofacial inflammatory pain in mouse models. The research provides new mechanistic insights, highlighting the role of endocannabinoid and serotonergic pathways in mediating CBD's multidimensional analgesic and mood-stabilizing effects.
-
ARCA EGFP mRNA: Optimizing Mammalian Transfection Assays
2026-06-13
ARCA EGFP mRNA enables robust, direct fluorescence-based measurement of transfection efficiency in mammalian cells, setting a new standard for reproducible gene expression workflows. Leveraging its advanced ARCA co-transcriptional capping and stability enhancements, this reporter mRNA streamlines assay optimization and troubleshooting, especially in challenging cell types.
-
GSTA1 Drives Glutathione Depletion in α-Amanitin Hepatotoxic
2026-06-12
This study reveals that GSTA1, instead of protecting hepatocytes, paradoxically promotes glutathione depletion and oxidative stress in α-amanitin-induced liver injury. These insights reframe the NRF2-GSTA1 axis as a potential therapeutic target and diagnostic biomarker in acute hepatotoxicity models.
-
MDM1 Overexpression Enhances Apoptotic Sensitivity in Colore
2026-06-12
This study reveals that increased MDM1 expression in colorectal cancer cells upregulates p53 and apoptosis, thereby improving sensitivity to chemoradiotherapy. The findings establish MDM1 as a potential predictive biomarker and therapeutic target for overcoming treatment resistance.
-
Hematoxylin and Eosin Staining Kit: Reliable Tissue Morpholo
2026-06-11
The Hematoxylin and Eosin Staining Kit (SKU K1142) provides standardized, ready-to-use reagents for precise tissue morphology visualization and cellular structure assessment in research settings. This kit streamlines histopathological and cytological staining of paraffin-embedded or frozen tissue sections, but is not intended for diagnostic or clinical use. Researchers requiring robust, reproducible nuclear and cytoplasmic contrast in tissue analysis will benefit from its straightforward workflow and stable formulations.
-
Gingerenone A Reverses Sunitinib Resistance in Renal Cancer
2026-06-11
This study identifies gingerenone A as a metabolic inhibitor that suppresses LDHA-mediated glycolysis and overcomes resistance to sunitinib in renal cell carcinoma. By disrupting the HIF-1α/VEGFA/VEGFR2 axis, gingerenone A restores drug sensitivity and offers a promising adjuvant strategy for RCC therapy.
-
Developmental Gradients of Nurr1+ Neurons in Rat Claustrum
2026-06-10
Fang et al. (2021) delineate the spatial and temporal emergence of Nurr1 positive neurons within the rat claustrum and adjacent lateral cortex, clarifying previously conflicting birth dating patterns. Their findings refine our understanding of claustral development and provide a foundation for precise neurogenetic mapping in rodent models.
-
ARCA EGFP mRNA: Elevating Transfection Controls in Translati
2026-06-10
Translational gene delivery relies on robust, reproducible measurement of mRNA uptake and expression. This thought-leadership article unpacks the mechanistic strengths of ARCA EGFP mRNA as a next-generation transfection control, connecting the latest advances in direct-detection reporter design with strategic guidance for researchers optimizing delivery to mammalian cells—including hard-to-transfect immune subtypes. By bridging recent lipid nanoparticle innovations and the unique stability conferred by ARCA capping and poly(A) tail optimization, the article positions ARCA EGFP mRNA as a critical tool for workflow validation and delivery platform benchmarking.
-
Vorinostat (SAHA, MK0683): Precision Epigenetic Modulation i
2026-06-09
Discover the advanced scientific utility of Vorinostat (suberoylanilide hydroxamic acid) as a potent HDAC inhibitor for precision epigenetic modulation in oncology. This article provides a unique, protocol-focused perspective, integrating real-time HO-1 assay innovations with practical guidance for cancer biology research.
-
JHU-083: Advancing Glutaminase Pathway Research in Neurologi
2026-06-09
This thought-leadership article examines the mechanistic and translational significance of JHU-083, a potent 6-diazo-5-oxo-L-norleucine precursor, in glutaminase pathway research. By integrating insights on glutamate excitotoxicity, oxidative stress, and the paradoxical role of detoxification enzymes in disease, it provides strategic guidance for translational researchers seeking to design robust neurological disease models and therapeutic assays. The article contextualizes JHU-083’s advantages within the emerging landscape of redox biology and experimental cerebral malaria, referencing recent evidence and internal content assets to establish a forward-looking research agenda.
-
Allosteric PDK4 Inhibitors: New Avenues for Metabolic Diseas
2026-06-08
This article reviews the discovery and characterization of novel allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), which show nanomolar potency and oral activity. The reference study demonstrates meaningful therapeutic potential in metabolic disease, allergy, and cancer models, with direct implications for translational research on mitochondrial energy metabolism.
-
Sulfo-Cy5 Carboxylic Acid: High-Fidelity Fluorescent Dye for
2026-06-08
Sulfo-Cy5 carboxylic acid is a sulfonated, hydrophilic fluorescent dye that offers superior water solubility and robust fluorescence with minimized quenching. As a primary fluorescent dye for life sciences, it excels in protein and peptide labeling workflows, particularly in aqueous conditions. Its validated benchmarks and mechanistic clarity make it a reference choice for advanced imaging and neuroscience applications.
-
GSTA1 Drives Glutathione Depletion in α-Amanitin Hepatotoxic
2026-06-07
This study uncovers a paradoxical mechanism by which GSTA1, a key hepatic antioxidant enzyme, exacerbates α-amanitin-induced liver injury through glutathione depletion and intensified oxidative stress. The findings reposition GSTA1 as a direct pathogenic driver and potential therapeutic target in acute hepatotoxicity, with implications for biomarker discovery and intervention strategies.